Jove
Visualize
Contact Us

Related Experiment Videos

Rotavirus vaccine, live, oral, tetravalent (RotaShield).

C Hochwald1, L Kivela

  • 1Hermann Children's Hospital, Houston, TX, USA.

Pediatric Nursing
|October 26, 1999
PubMed
Summary

Nearly all children contract rotavirus before age five, causing severe diarrhea and dehydration, especially in young children. Mass vaccination with RotaShield can significantly reduce rotavirus illness and associated indirect costs for families.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronotype, daily affect and social contact: An ecological momentary assessment study.

Psychiatry research·2022
Same author

Omeprazole (Prilosec).

Pediatric nursing·1996
Same author

Intravenous immunoglobulin.

Pediatric nursing·1996
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Rotavirus infection is a common childhood illness, transmitted via the fecal-oral route.
  • It causes severe gastroenteritis, leading to dehydration and potentially death in children under two.
  • Outbreaks frequently occur in pediatric settings due to viral shedding in stool.

Purpose of the Study:

  • To highlight the significant health burden of rotavirus infection in young children.
  • To emphasize the economic and social impact of rotavirus on families.
  • To advocate for the implementation of RotaShield vaccination to mitigate these effects.

Main Methods:

  • The study summarizes existing knowledge on rotavirus transmission, clinical presentation, and epidemiology.
  • It analyzes the indirect costs associated with rotavirus illness, including parental work absence and healthcare utilization.
  • The potential impact of mass vaccination on reducing these costs is discussed.

Main Results:

  • Rotavirus infection affects nearly all children before age five, causing significant morbidity and mortality worldwide.
  • In the US, it leads to 70,000 hospitalizations and 100 deaths annually, with substantial indirect costs for families.
  • Worldwide, rotavirus causes approximately 1 million deaths each year.

Conclusions:

  • Rotavirus infection poses a major public health challenge globally and in the US.
  • Mass vaccination with RotaShield is a viable strategy to significantly decrease rotavirus-related illnesses and their associated economic burden.
  • Vaccination offers a critical solution for preventing severe rotavirus disease and its societal impact.

Related Experiment Videos